Compare Shanghai MicroPort MedBot (Group) Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 30.12% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -56.23
2
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
HKD 24,901 Million ()
NA (Loss Making)
NA
0.00%
-0.26
-45.56%
42.48
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2021)
Net Profit:
-154 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.71%
0%
21.71%
6 Months
26.32%
0%
26.32%
1 Year
49.01%
0%
49.01%
2 Years
112.59%
0%
112.59%
3 Years
-12.77%
0%
-12.77%
4 Years
-41.07%
0%
-41.07%
5 Years
0%
0%
0.0%
Shanghai MicroPort MedBot (Group) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
116.40%
EBIT Growth (5y)
30.12%
EBIT to Interest (avg)
-56.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
68.61
EV to EBIT
-74.78
EV to EBITDA
-76.91
EV to Capital Employed
55.34
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-74.00%
ROE (Latest)
-90.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
278.90
115.60
141.26%
Operating Profit (PBDIT) excl Other Income
-398.90
-892.30
55.30%
Interest
23.50
20.50
14.63%
Exceptional Items
-134.90
-47.00
-187.02%
Consolidate Net Profit
-701.60
-1,131.00
37.97%
Operating Profit Margin (Excl OI)
-1,888.10%
-8,789.10%
690.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 141.26% vs 360.56% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 37.97% vs 15.15% in Dec 2023
About Shanghai MicroPort MedBot (Group) Co., Ltd. 
Shanghai MicroPort MedBot (Group) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






